KeyBanc Capital Markets raised the price target for the Global Medical REIT Inc. (NYSE:GMRE) stock from ‘an Overweight’ to ‘a Sector weight’. The rating was released on January 13, 2023, according to finviz. The research report from Colliers Securities has initiated the stock to Buy, with a price target set at $18. The stock was initiated by BMO Capital Markets, who disclosed in a research note on April 16, 2021, to Outperform and set the price objective to $16. In their research brief published September 30, 2020, Robert W.